Syrona Women company

Syrona Women develops a non-invasive cancer screening kit designed to facilitate early stage detection of gynecological cancers at home. The company's kit combines an automated diagnostic technology and a unique sample that enables detection of multiple novel biomarkers indicative of STIs and reproductive cancers, STDs and gynecological cancers so as to let women screen and manage their own reproductive health at homes, enabling women to keep a check of their gynecological health by themselves without having to wait for time-consuming diagnostics in clinics.
Technology: Longevity FemTech
Industry: Health Care
Headquarters: London, England, United Kingdom
Founded Date: 2018-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 2
Total Funding: $678.9K
Estimated Revenue: Less than $1M
Last Funding Type: Grant

Visit Website
Register and Claim Ownership